108 related articles for article (PubMed ID: 15998521)
21. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice.
Furuya DT; Poletto AC; Favaro RR; Martins JO; Zorn TM; Machado UF
Metabolism; 2010 Mar; 59(3):395-9. PubMed ID: 19800637
[TBL] [Abstract][Full Text] [Related]
23. Effects of atorvastatin on the regeneration of pancreatic {beta}-cells after streptozotocin treatment in the neonatal rodent.
Marchand KC; Arany EJ; Hill DJ
Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E92-E100. PubMed ID: 20388824
[TBL] [Abstract][Full Text] [Related]
24. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression.
Moon JH; Kang SB; Park JS; Lee BW; Kang ES; Ahn CW; Lee HC; Cha BS
Metabolism; 2011 Jul; 60(7):930-40. PubMed ID: 20951395
[TBL] [Abstract][Full Text] [Related]
26. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
27. In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats.
Marzban L; Bhanot S; McNeill JH
Mol Cell Biochem; 2001 Jul; 223(1-2):147-57. PubMed ID: 11681716
[TBL] [Abstract][Full Text] [Related]
28. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
[TBL] [Abstract][Full Text] [Related]
29. Dietary conjugated linoleic acid preserves pancreatic function and reduces inflammatory markers in obese, insulin-resistant rats.
Noto A; Zahradka P; Ryz NR; Yurkova N; Xie X; Taylor CG
Metabolism; 2007 Jan; 56(1):142-51. PubMed ID: 17161237
[TBL] [Abstract][Full Text] [Related]
30. Direct adipotropic actions of atorvastatin: differentiation state-dependent induction of apoptosis, modulation of endocrine function, and inhibition of glucose uptake.
Mäuser W; Perwitz N; Meier B; Fasshauer M; Klein J
Eur J Pharmacol; 2007 Jun; 564(1-3):37-46. PubMed ID: 17376428
[TBL] [Abstract][Full Text] [Related]
31. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
Chen GP; Yao L; Lu X; Li L; Hu SJ
Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo.
Schneider JG; von Eynatten M; Parhofer KG; Volkmer JE; Schiekofer S; Hamann A; Nawroth PP; Dugi KA
Atherosclerosis; 2004 Aug; 175(2):325-31. PubMed ID: 15262189
[TBL] [Abstract][Full Text] [Related]
33. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
Dokken BB; Henriksen EJ
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
[TBL] [Abstract][Full Text] [Related]
34. HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats.
Satoh K; Keimatsu N; Kanda M; Kasai T; Takaguri A; Sun F; Ichihara K
Biol Pharm Bull; 2005 Nov; 28(11):2092-5. PubMed ID: 16272695
[TBL] [Abstract][Full Text] [Related]
35. Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum/mitochondria Ca2+-release system.
Liantonio A; Giannuzzi V; Cippone V; Camerino GM; Pierno S; Camerino DC
J Pharmacol Exp Ther; 2007 May; 321(2):626-34. PubMed ID: 17293561
[TBL] [Abstract][Full Text] [Related]
36. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin prevented and reversed dexamethasone-induced hypertension in the rat.
Mondo CK; Yang WS; Su JZ; Huang TG
Clin Exp Hypertens; 2006 Jul; 28(5):499-509. PubMed ID: 16820346
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
Whaley-Connell A; DeMarco VG; Lastra G; Manrique C; Nistala R; Cooper SA; Westerly B; Hayden MR; Wiedmeyer C; Wei Y; Sowers JR
Am J Nephrol; 2008; 28(1):67-75. PubMed ID: 17914247
[TBL] [Abstract][Full Text] [Related]
39. Differential metabolic effects of distinct statins.
Koh KK; Sakuma I; Quon MJ
Atherosclerosis; 2011 Mar; 215(1):1-8. PubMed ID: 21130454
[TBL] [Abstract][Full Text] [Related]
40. Glucose metabolism in perfused skeletal muscle. Demonstration of insulin resistance in the obese Zucker rat.
Kemmer FW; Berger M; Herberg L; Gries FA; Wirdeier A; Becker K
Biochem J; 1979 Mar; 178(3):733-41. PubMed ID: 454379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
